Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
CB Financial Services
CBFV
$193M
| $958K | ﹤0.01% |
44,309
+3,784
| +9% | +$86.9K |
|
|
UHG
3377
DELISTED
United Homes Group
UHG
| $958K | ﹤0.01% |
137,059
+4,140
| +3% | +$31K |
|
3378
Offerpad Solutions
OPAD
$23.1M
| $956K | ﹤0.01% |
11,796
-549
| -4% | -$48.1K |
|
|
CRON
3379
Cronos Group
CRON
$1.14B
| $955K | ﹤0.01% |
365,934
+105,217
| +40% | +$226K |
|
3380
Beam Global
BEEM
$25.3M
| $955K | ﹤0.01% |
140,404
-2,065
| -1% | -$14.1K |
|
3381
Ascent Industries
ACNT
$141M
| $953K | ﹤0.01% |
93,534
+8,400
| +10% | +$86.2K |
|
3382
Stratasys
SSYS
$774M
| $952K | ﹤0.01% |
81,967
+190
| +0.2% | +$2.44K |
|
3383
Protalix BioTherapeutics
PLX
$198M
| $950K | ﹤0.01% |
754,110
+29,535
| +4% | +$44.1K |
|
3384
Achieve Life Sciences
ACHV
$683M
| $940K | ﹤0.01% |
206,784
+21,859
| +12% | +$97K |
|
3385
Citizens
CIA
$192M
| $939K | ﹤0.01% |
438,465
+3,094
| +0.7% | +$8.07K |
|
3386
P3 Health Partners
PIII
$38.5M
| $937K | ﹤0.01% |
18,190
+1,269
| +7% | +$70.5K |
|
3387
SB Financial Group
SBFG
$169M
| $935K | ﹤0.01% |
67,830
| – | – |
|
|
WHWK
3388
Whitehawk Therapeutics
WHWK
$271M
| $934K | ﹤0.01% |
399,231
+3,374
| +0.9% | +$6.5K |
|
3389
Value Line
VALU
$361M
| $932K | ﹤0.01% |
23,007
+705
| +3% | +$30.2K |
|
|
TVRD
3390
Tvardi Therapeutics
TVRD
$23.4M
| $930K | ﹤0.01% |
28,378
+351
| +1% | +$9.1K |
|
3391
Algoma Steel
ASTL
$431M
| $928K | ﹤0.01% |
109,105
-184,826
| -63% | -$1.56M |
|
3392
Blue Ridge Bankshares
BRBS
$332M
| $925K | ﹤0.01% |
343,800
+15,917
| +5% | +$43.3K |
|
3393
Immatics
IMTX
$1.32B
| $925K | ﹤0.01% |
87,966
+3,659
| +4% | +$42.7K |
|
|
VINC
3394
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $924K | ﹤0.01% |
9,124
+1,422
| +18% | +$89.9K |
|
|
FNCB
3395
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $923K | ﹤0.01% |
151,957
+3,288
| +2% | +$20.4K |
|
|
MKFG
3396
DELISTED
Markforged Holding Corporation
MKFG
| $920K | ﹤0.01% |
110,037
+614
| +0.6% | +$4.4K |
|
3397
Westwood Holdings Group
WHG
$190M
| $917K | ﹤0.01% |
74,399
-1,318
| -2% | -$15.9K |
|
3398
Metagenomi Therapeutics
MGX
$46.3M
| $915K | ﹤0.01% |
+86,763
| New | +$997K |
|
|
HOLI
3399
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $914K | ﹤0.01% |
35,748
| – | – |
|
|
HMNF
3400
DELISTED
HMN Financial Inc
HMNF
| $913K | ﹤0.01% |
43,244
-304
| -0.7% | -$6.47K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.